» Articles » PMID: 35907105

Relations Between Recurrence Risk Perceptions and Fear of Cancer Recurrence in Breast Cancer Survivors

Overview
Specialty Oncology
Date 2022 Jul 30
PMID 35907105
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aimed to: (1) determine the accuracy of Dutch breast cancer survivors' estimations of the locoregional recurrence risk (LRR); (2) examine which variables influence (the accuracy of) risk estimations, and risk appraisals; and (3) investigate the influence of the objective LRR risk (estimated using the INFLUENCE-nomogram), risk estimations and risk appraisals on fear of cancer recurrence (FCR). Findings of this study will inform clinicians on risk communication and can improve communication about FCR.

Methods: In a cross-sectional survey among 258 breast cancer survivors, women's recurrence risk estimations (in odds) and risk appraisals (in high/low), FCR, demographics and illness perceptions, about one year after surgery were measured and compared to the objective risk for LRRs estimated using the INFLUENCE-nomogram.

Results: Half of the women (54%) accurately estimated their LRR risk, 34% underestimated and 13% overestimated their risk. Risk estimations and risk appraisals were only moderately positively correlated (r = 0.58). Higher risk appraisals were associated with radiotherapy (r = 0.18) and having weaker cure beliefs (r = - 0.19). Younger age was associated with overestimation of risk (r = - 0.23). Recurrence risk estimations and risk appraisals were associated with more FCR (r = 0.29, r = 0.39). In regression, only risk appraisal contributed significantly to FCR.

Conclusion: Although women were fairly accurate in recurrence risk estimations, it remains difficult to predict over- or underestimation. Recurrence risk estimations and risk appraisal are two different concepts which are both associated with FCR and should therefore be addressed in patient-provider communication.

Citing Articles

How perceived risk of recurrence strengthens health management awareness in stroke patients: the chain mediating role of risk fear and health literacy.

Lei R, Zhang M, Gui G, Yang D, He L Front Public Health. 2025; 13:1524492.

PMID: 40051512 PMC: 11882430. DOI: 10.3389/fpubh.2025.1524492.


Perception of recurrence risk in patients with IgG4-related disease: a descriptive phenomenological study.

Yu K, Gao H, Liu S, Yao H, Wang X, Luo C Rheumatol Adv Pract. 2024; 9(1):rkae148.

PMID: 39717021 PMC: 11665928. DOI: 10.1093/rap/rkae148.


Patient-reported outcomes, and perceptions and knowledge about recurrence in women with hormone receptor-positive breast cancer.

Rosenberg S, Zheng Y, Santos K, Riley E, Meadows H, Snow C Breast Cancer Res Treat. 2024; 209(3):513-520.

PMID: 39432162 DOI: 10.1007/s10549-024-07510-8.


Psychological impact of exceptional response in people with advanced cancer: a qualitative exploration.

Wahab S, Joshua A, Dhillon H, Barnet M J Cancer Surviv. 2024; .

PMID: 39141308 DOI: 10.1007/s11764-024-01655-7.


Is de-escalation of treatment by omission of radiotherapy associated with fear of cancer recurrence in women with early breast cancer? An exploratory study.

Stafford L, Sinclair M, Butow P, Hughes J, Park A, Gilham L Breast Cancer Res Treat. 2023; 201(3):367-376.

PMID: 37480383 PMC: 10460737. DOI: 10.1007/s10549-023-07039-2.


References
1.
Moon Z, Moss-Morris R, Hunter M, Hughes L . Measuring illness representations in breast cancer survivors (BCS) prescribed tamoxifen: Modification and validation of the Revised Illness Perceptions Questionnaire (IPQ-BCS). Psychol Health. 2017; 32(4):439-458. DOI: 10.1080/08870446.2016.1275629. View

2.
Ankersmid J, Drossaert C, van Riet Y, Strobbe L, Siesling S . Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance. J Cancer Surviv. 2022; 17(5):1471-1479. PMC: 10442247. DOI: 10.1007/s11764-022-01178-z. View

3.
Burm R, Thewes B, Rodwell L, Kievit W, Speckens A, van de Wal M . Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial. BMC Cancer. 2019; 19(1):462. PMC: 6524293. DOI: 10.1186/s12885-019-5615-3. View

4.
Liu J, Butow P, Beith J . Systematic review of interventions by non-mental health specialists for managing fear of cancer recurrence in adult cancer survivors. Support Care Cancer. 2019; 27(11):4055-4067. DOI: 10.1007/s00520-019-04979-8. View

5.
Liu Y, Perez M, Aft R, Massman K, Robinson E, Myles S . Accuracy of perceived risk of recurrence among patients with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev. 2010; 19(3):675-80. PMC: 2836416. DOI: 10.1158/1055-9965.EPI-09-1051. View